5 modules

The heterogeneity of TNBC: are we ready to implement the biological knowledge in the clinical practice?

Dr. Phillipe Aftimos, Institut Jules Bordet (Brussels, Belgium)
Dr. Mafalda Oliveira, Hospital Vall d’Hebron/VHIO (Barcelona, Spain)

4 módulos

Treatment of early TNBC: what is the current optimal algorithm?

Dr. Sara López Tarruella, Hospital General Universitario Gregorio Marañón (Madrid, Spain)
Dr. Mireia Margelí, Institut Català d’Oncologia-Badalona (Barcelona, Spain)

4 módulos

Immunotherapy in early TNBC

Dr. Marta Santisteban, Clínica Universidad de Navarra (Pamplona, Spain)
Dr. Luis de la Cruz, Hospital Universitario Virgen Macarena (Sevilla, Spain)

4 módulos

Using biomarkers to define the best first-line strategy in mTNBC

Dr. Roberto Salgado, GZA-ZNA Hospitals (Antwerp, Belgium), Peter Mac Callum Cancer Centre (Melbourne, Australia)
Dr. Vicente Peg, Hospital Universitario Valle de Hebrón (Barcelona, Spain)

4 módulos

Novel treatment approaches in mTNBC

Dr. Kevin Punie, UZ Leuven (Leuven, Belgium)
Dr. Arlindo Ferreira, Champalimaud Foundation (Lisbon, Portugal)